Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Guided Therapeutics (GTHP) Leases (2019 - 2025)

Guided Therapeutics' Leases history spans 7 years, with the latest figure at $686000.0 for Q4 2025.

  • On a quarterly basis, Leases rose 386.52% to $686000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $686000.0, a 386.52% increase, with the full-year FY2025 number at $686000.0, up 386.52% from a year prior.
  • Leases hit $686000.0 in Q4 2025 for Guided Therapeutics, up from $69000.0 in the prior quarter.
  • Over the last five years, Leases for GTHP hit a ceiling of $686000.0 in Q4 2025 and a floor of $69000.0 in Q3 2025.
  • Historically, Leases has averaged $279750.0 across 5 years, with a median of $275500.0 in 2023.
  • Biggest five-year swings in Leases: soared 536.07% in 2021 and later crashed 57.93% in 2025.
  • Tracing GTHP's Leases over 5 years: stood at $372000.0 in 2021, then decreased by 18.55% to $303000.0 in 2022, then fell by 25.08% to $227000.0 in 2023, then tumbled by 37.89% to $141000.0 in 2024, then soared by 386.52% to $686000.0 in 2025.
  • Business Quant data shows Leases for GTHP at $686000.0 in Q4 2025, $69000.0 in Q3 2025, and $94000.0 in Q2 2025.